MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from issuance of co...
Amortization of penalty on promi...
Issuance of common stock to cons...
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Repayment of promissory notes
Provision for credit losses of s...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
2025-03-31
Loss from discontinued operations, net of tax
0
-
-
Net loss from continuing operations
-2,037,819
-
-
Net loss
-6,369,407
-
-
Change in fair value of derivative liabilities
0
0
-
Gain on voluntary conversion of convertible debt
0
-
-
Loss on monthly redemptions of convertible debt into common stock
0
0
-
Accretion of discount on convertible debt
0
0
-
Gain on change in fair value of derivative liabilities
0
-
-
Fair value of warrant modification for professional services
0
0
-
Net loss from continuing operations
-2,037,819
-4,331,588
-
Stock-based compensation
0
0
269
Change in fair value of warrant liabilities
148,347
-15,974
-39,225
Legal expenses deducted from issuance of converftible debt
0
20,000
-
Amortization of accrued penalty on notes payable
-
-
73,615
Issuance of common stock to consultant
325,635
-
-
Accrued interest on short-term note receivable
177,611
140,433
110,871
Gain on voluntary conversion of convertible debt
-
0
-
Amortization of penalty on promissory note
455,940
179,667
-
Loss on issuance of convertible debt
0
-91,943
-
Loss on change in fair value of convertible debt
-197,667
37,874
-
Prepaid expenses and other assets
26,515
-269,189
-913,454
Accounts payable
-122,387
-126,124
-37,330
Accrued expenses and other current liabilities
-337,737
149,529
59,861
Provision for credit losses of short-term note receivable
-567,000
271,000
197,000
Net cash used in operating activities
-2,141,478
-1,098,111
-1,589,396
Net cash provided by investing activities - discontinued operations
0
0
-
Issuance of short-term note receivable
291,000
1,213,500
305,000
Net cash used in investing activities
-291,000
-1,213,500
-305,000
Net cash provided by financing activities - discontinued operations
0
0
0
Proceeds from issuance of common shares and prefunded warrants in public offering
0
-
-
Proceeds from warrant exercises
0
0
-
Proceeds from the issuance of convertible debt
0
200,000
-
Net proceeds from issuance of common and preferred shares in private placement
41,911,544
-
-
Repayment of convertible debt
0
132,000
-
Proceeds from issuance of short term debt
-
-
750,000
Repayment of promissory notes
1,033,500
-
-
Proceeds from the issuance of convertible notes payable
-
-
0
Proceeds from issuance of promissory notes
0
3,295,000
-
Net cash provided by financing activities - continuing operations
40,878,044
2,613,000
750,000
Net cash provided by financing activities
40,878,044
2,613,000
750,000
Net change in cash and cash equivalents
38,445,565
301,389
-1,144,396
Cash and cash equivalents at beginning of period
1,174,608
-
-
Cash and cash equivalents at end of period
38,777,166
-
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
issuance of common and...
$41,911,544
Net cash provided by
financing activities -...
$40,878,044
Canceled cashflow
$1,033,500
Net cash provided by
financing activities
$40,878,044
Repayment of promissory
notes
$1,033,500
Net change in cash
and cash...
$38,445,565
Canceled cashflow
$2,432,478
Amortization of penalty on
promissory note
$455,940
Issuance of common stock
to consultant
$325,635
Loss on change in fair
value of convertible...
-$197,667
Change in fair value of
warrant liabilities
$148,347
Net cash used in
operating activities
-$2,141,478
Net cash used in
investing activities
-$291,000
Canceled cashflow
$1,127,589
something is missing
$4,331,588
Net loss from
continuing operations
-$2,037,819
Provision for credit
losses of short-term...
-$567,000
Issuance of short-term
note receivable
$291,000
Canceled cashflow
$4,331,588
Accrued expenses and
other current...
-$337,737
Accrued interest on
short-term note receivable
$177,611
Accounts payable
-$122,387
Prepaid expenses and
other assets
$26,515
Net loss
-$6,369,407
something is missing
-$4,331,588
Net loss from
continuing operations
-$2,037,819
Buy us a coffee
Qualigen Therapeutics, Inc. (QLGN)
Qualigen Therapeutics, Inc. (QLGN)